Gita Ramjee

Q: What Schools Are Affiliated With Gita Ramjee

Gita Ramjee is affiliated with the following schools: University of Cape Town, University of Sunderland, University of KwaZulu-Natal, University of Washington, London School of Hygiene and Tropical Medicine

Gita Ramjee's AcademicInfluence.com Rankings

Gita Ramjee

Philosophy

#10068

World Rank

#13767

Historical Rank

Logic

#7773

World Rank

#9639

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Gita Ramjee Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Gita Ramjee was a Ugandan-South African scientist and researcher in HIV prevention. In 2018, she was awarded the ‘Outstanding Female Scientist’ award from the European and Developing Countries Clinical Trials Partnership. She died in Umhlanga, Durban, South Africa, from COVID-19 related complications.

(See a Problem?)

Gita Ramjee's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Tenofovir-based preexposure prophylaxis for HIV infection among African women. (2015) (1081)
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial (2002) (842)
Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial (2008) (526)
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. (2016) (470)
Lack of effectiveness of cellulose sulfate gel for the prevention of vaginal HIV transmission. (2008) (449)
Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: a randomised controlled trial (2007) (369)
PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial (2010) (350)
Women and HIV in Sub-Saharan Africa (2013) (256)
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women (2011) (236)
Short-course antiretroviral therapy in primary HIV infection. (2013) (208)
Prevalence of HIV Among Truck Drivers Visiting Sex Workers in KwaZulu-Natal, South Africa (2002) (203)
Microbicide acceptability research: current approaches and future directions. (2005) (181)
Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. (2003) (134)
Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. (2004) (132)
Epidemiological Synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African Women (2010) (130)
Regional Clustering of Shared Neutralization Determinants on Primary Isolates of Clade C Human Immunodeficiency Virus Type 1 from South Africa (2002) (127)
Sexually Transmitted Infections Among Sex Workers in KwaZulu‐Natal, South Africa (1998) (120)
Nonoxynol-9 spermicide for prevention of vaginally acquired HIV and other sexually transmitted infections: systematic review and meta-analysis of randomised controlled trials including more than 5000 women. (2002) (118)
Towards host-directed therapies for tuberculosis (2015) (104)
Hormonal contraception and the risk of HIV acquisition among women in South Africa (2012) (98)
Targeting the hotspots: investigating spatial and demographic variations in HIV infection in small communities in South Africa (2010) (98)
Safety of multiple daily applications of COL-1492, a nonoxynol-9 vaginal gel, among female sex workers (2000) (91)
Anal sex and HIV transmission in women. (1998) (88)
The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections (2012) (82)
The relationship between age of coital debut and HIV seroprevalence among women in Durban, South Africa: a cohort study (2012) (79)
Recording sexual behavior: comparison of recall questionnaires with a coital diary. (1999) (78)
The Impact of Incident and Prevalent Herpes Simplex Virus-2 Infection on the Incidence of HIV-1 Infection Among Commercial Sex Workers in South Africa (2005) (76)
Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy (2013) (75)
Bacterial Vaginosis and the Risk of Trichomonas vaginalis Acquisition Among HIV-1–Negative Women (2014) (71)
High prevalence and incidence of sexually transmitted infections among women living in Kwazulu-Natal, South Africa (2014) (68)
The Effectiveness of Carraguard, a Vaginal Microbicide, in Protecting Women against High-Risk Human Papillomavirus Infection (2011) (66)
The acceptability of a vaginal microbicide among South African men. (2001) (63)
Combined Impact of Sexual Risk Behaviors for HIV Seroconversion Among Women in Durban, South Africa: Implications for Prevention Policy and Planning (2011) (61)
South Africa's Experience of the Closure of the Cellulose Sulphate Microbicide Trial (2007) (59)
The Value of Site Preparedness Studies for Future Implementation of Phase 2/IIb/III HIV Prevention Trials: Experience From the HPTN 055 Study (2008) (56)
The Diaphragm and Lubricant Gel for Prevention of Cervical Sexually Transmitted Infections: Results of a Randomized Controlled Trial (2008) (55)
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study. (2015) (53)
Assessing the Reporting of Adherence and Sexual Activity in a Simulated Microbicide Trial in South Africa: An Interview Mode Experiment Using a Placebo Gel (2011) (53)
Nonoxynol-9 for preventing vaginal acquisition of HIV infection by women from men. (2002) (52)
Acceptability of Carraguard, a candidate microbicide and methyl cellulose placebo vaginal gels among HIV-positive women and men in Durban, South Africa (2007) (51)
Patterns of infection: using age prevalence data to understand epidemic of HIV in South Africa (2000) (50)
Aflatoxins and kwashiorkor in Durban, South Africa. (1992) (50)
High-Risk Human Papillomavirus Is Associated with HIV Acquisition among South African Female Sex Workers (2011) (49)
Intimate Partner Violence and Condom and Diaphragm Nonadherence Among Women in an HIV Prevention Trial in Southern Africa (2013) (49)
Challenges in the conduct of vaginal microbicide effectiveness trials in the developing world (2000) (47)
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study. (2021) (47)
Geoadditive models to assess spatial variation of HIV infections among women in Local communities of Durban, South Africa (2011) (46)
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection (2014) (46)
Nonoxynol-9 for preventing vaginal acquisition of sexually transmitted infections by women from men. (2002) (45)
Risk Factors for Incidence of Sexually Transmitted Infections Among Women in South Africa, Tanzania, and Zambia: Results From HPTN 055 Study (2009) (45)
Carraguard Vaginal Gel Safety in HIV-Positive Women and Men in South Africa (2007) (45)
The last decade of microbicide clinical trials in Africa: from hypothesis to facts (2010) (44)
Provision of antiretroviral therapy in South Africa: unique challenges and remaining obstacles. (2007) (44)
"We have our protector": misperceptions of protection against HIV among participants in a microbicide efficacy trial. (2006) (43)
Efficacy of an alcohol-focused intervention for improving adherence to antiretroviral therapy (ART) and HIV treatment outcomes – a randomised controlled trial protocol (2014) (42)
Experiences in conducting multiple community-based HIV prevention trials among women in KwaZulu-Natal, South Africa (2010) (42)
Trends in Pretreatment HIV-1 Drug Resistance in Antiretroviral Therapy-naive Adults in South Africa, 2000–2016: A Pooled Sequence Analysis (2019) (42)
Prevalent bacterial vaginosis infection – a risk factor for incident sexually transmitted infections in women in Durban, South Africa (2016) (41)
Injectable and oral contraceptives and risk of HIV acquisition in women: an analysis of data from the MDP301 trial (2014) (40)
Geographical Clustering of High Risk Sexual Behaviors in “Hot-Spots” for HIV and Sexually Transmitted Infections in Kwazulu-Natal, South Africa (2013) (39)
HIV Incidence Among Non-Pregnant Women Living in Selected Rural, Semi-Rural and Urban Areas in Kwazulu-Natal, South Africa (2011) (38)
Contribution of elevated protein turnover and anorexia to cachexia in patients with hepatocellular carcinoma. (1990) (37)
A Simple Risk Prediction Algorithm for HIV Transmission: Results from HIV Prevention Trials in KwaZulu Natal, South Africa (2002–2012) (2017) (36)
High prevalence of obesity among women who enrolled in HIV prevention trials in KwaZulu-Natal, South Africa: healthy diet and life style messages should be integrated into HIV prevention programs (2013) (35)
CD32-Expressing CD4 T Cells Are Phenotypically Diverse and Can Contain Proviral HIV DNA (2018) (34)
The impact of human immunodeficiency virus type 1 status on human papillomavirus (HPV) prevalence and HPV antibodies in serum and cervical secretions. (2000) (34)
Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. (2007) (33)
Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009) (2013) (33)
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection (2016) (32)
HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women (2014) (32)
Age-Disparate Partnerships and Risk of HIV-1 Acquisition Among South African Women Participating in the VOICE Trial (2015) (32)
Ethical considerations in determining standard of prevention packages for HIV prevention trials: examining PrEP. (2013) (31)
Vaginal insertion and douching practices among sex workers at truck stops in KwaZulu-Natal. (1998) (31)
Provision of long‐acting reversible contraception in HIV‐prevalent countries: results from nationally representative surveys in southern Africa (2013) (30)
Determinants of Differential HIV Incidence Among Women in Three Southern African Locations (2011) (30)
The generational effect on age disparate partnerships and the risk for human immunodeficiency virus and sexually transmitted infections acquisition (2016) (30)
Acceptability and Use of the Diaphragm and Replens® Lubricant Gel for HIV Prevention in Southern Africa (2009) (29)
Conserved domains of subtype C nef from South African HIV type 1-infected individuals include cytotoxic T lymphocyte epitope-rich regions. (2001) (28)
Point-of-care HIV testing best practice for early infant diagnosis: an implementation study (2019) (28)
Novel strategies implemented to ensure high participant retention rates in a community based HIV prevention effectiveness trial in South Africa and Zimbabwe. (2009) (28)
Acceptability of COL-1492, a vaginal gel, among sex workers in one Asian and three African cities (2004) (28)
Incidence of Sexually Transmitted Infections Among HIV-Positive Sex Workers in KwaZulu-Natal, South Africa (2002) (27)
Patterns and Predictors of Adherence to Diaphragm Use in a Phase III Trial in Sub-Saharan Africa: A Trajectory Analysis (2009) (27)
The current status of the use of oral medication to prevent HIV transmission (2015) (26)
Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban: Prevalence, Coinfections, and Risk Factors (2013) (26)
Women and Sexually Transmitted Infections in Africa (2015) (26)
The impact of the use of COL-1492, a nonoxynol-9 vaginal gel, on the presence of cervical human papillomavirus in female sex workers. (2006) (26)
African Women Recently Infected With HIV-1 and HSV-2 Have Increased Risk of Acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa Trial (2011) (25)
User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa (2011) (25)
Protection of human subjects' rights in HIV-preventive clinical trials in Africa and Asia: experiences and recommendations (2001) (25)
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa. (2018) (24)
Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial. (2019) (24)
The relative contribution of viral and bacterial sexually transmitted infections on HIV acquisition in southern African women in the Methods for Improving Reproductive Health in Africa study (2011) (24)
HIV‐1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV‐16 antibodies in female sex workers (2009) (24)
Microbicides for HIV prevention (2007) (23)
Microbicides 2006 conference (2006) (23)
Microbicide research: current and future directions (2010) (23)
Individual and Population Level Impact of Key HIV Risk Factors on HIV Incidence Rates in Durban, South Africa (2016) (23)
Biological factors that place women at risk for HIV: evidence from a large-scale clinical trial in Durban (2016) (23)
Mucosal Escherichia coli bactericidal activity and immune mediators are associated with HIV-1 seroconversion in women participating in the HPTN 035 trial. (2012) (21)
Assessing and evaluating the combined impact of behavioural and biological risk factors for HIV seroconversion in a cohort of South African women (2012) (21)
A decade of sustained geographic spread of HIV infections among women in Durban, South Africa (2019) (21)
Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial. (2016) (20)
Prevalent Herpes Simplex Virus-2 Increases the Risk of Incident Bacterial Vaginosis in Women from South Africa (2018) (20)
Population-level impact of hormonal contraception on incidence of HIV infection and pregnancy in women in Durban, South Africa. (2012) (19)
Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa (2016) (18)
Immediate Blood Draw for CD4+ Cell Count Is Associated with Linkage to Care in Durban, South Africa: Findings from Pathways to Engagement in HIV Care (2016) (18)
The Use of the Diaphragm Instead of Condoms in a Phase III Diaphragm Trial (2009) (18)
Microbicides 2008 conference: From discovery to advocacy (2008) (17)
Acceptability of a vaginal microbicide among female sex workers (1999) (17)
Diaphragm and lubricant gel acceptance, skills and patterns of use among women in an effectiveness trial in Southern Africa (2009) (17)
Appropriateness of Hydroxyethylcellulose Gel as a Placebo Control in Vaginal Microbicide Trials: A Comparison of the Two Control Arms of HPTN 035 (2013) (17)
Perceptions of vaginal microbicides as an HIV prevention method among health care providers in KwaZulu-Natal, South Africa (2007) (17)
Targeting HIV-prevention efforts on truck drivers and sex workers: implications for a decline in the spread of HIV in southern Africa. (2001) (17)
Study protocol for a longitudinal study evaluating the impact of rape on women’s health and their use of health services in South Africa (2017) (17)
Microbicide acceptability: insights for future directions from providers and policy makers. (2008) (16)
Patterns of Infection: Using Age Prevalence and Incidence Data to Understand the Epidemic of HIV in South Africa (2000) (16)
Comparison of noninvasive methods for distinguishing steroid-sensitive nephrotic syndrome from focal glomerulosclerosis. (1997) (16)
Expanded safety and acceptability of the candidate vaginal microbicide Carraguard® in South Africa. (2010) (16)
Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models (2015) (16)
A nationally representative survey of healthcare provider counselling and provision of the female condom in South Africa and Zimbabwe (2013) (15)
Direct and indirect tests of pore size and charge selectivity in nephrotic syndrome. (1996) (15)
Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal (2015) (15)
“I did not see a need to get tested before, everything was going well with my health”: a qualitative study of HIV-testing decision-making in KwaZulu-Natal, South Africa (2018) (15)
The effect of the vaginal diaphragm and lubricant gel on acquisition of HSV-2 (2011) (15)
Detecting Mycobacterium tuberculosis using the loop-mediated isothermal amplification test in South Africa. (2017) (14)
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein (2020) (14)
Changes in Sexual Risk Behavior Before and After HIV Seroconversion in Southern African Women Enrolled in a HIV Prevention Trial (2011) (14)
High risk sexual behaviors are associated with sexual violence among a cohort of women in Durban, South Africa (2013) (13)
Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults (2012) (12)
Special Report on the State of HIV/AIDS in South Africa (2010) (12)
Short-term effects of an intravenous infusion of a nutrient solution containing amino acids, glucose and insulin on leucine turnover and amino acid metabolism in patients with liver failure. (1988) (11)
Clinical Evaluation of the OneStep Gonorrhea RapiCard InstaTest for Detection of Neisseria gonorrhoeae in Symptomatic Patients from KwaZulu-Natal, South Africa (2015) (11)
Good correlation between the Afinion AS100 analyser and the ABX Pentra 400 analyser for the measurement of glycosylated haemoglobin and lipid levels in older adults in Durban, South Africa. (2017) (11)
Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention. (2011) (11)
Male Circumcision for HIV Prevention: Clinical Practices and Attitudes Among Healthcare Providers in South Africa and Zimbabwe (2012) (10)
Spatial clustering of “measured” and “unmeasured” risk factors for HIV infections in hyper-endemic communities in KwaZulu-Natal, South Africa: results from geoadditive models (2015) (10)
Social Support and Violence-prone Relationships as Predictors of Disclosure of HIV Status Among Newly Diagnosed HIV-positive South Africans (2018) (9)
Research participants’ skills development as HIV prevention peer educators in their communities (2018) (9)
HIV Drug Resistance Patterns at the Epicentre of the HIV-1 Epidemic in Kwazulu-Natal, South Africa 2003-2013 (2014) (9)
Estimating prevalence and incidence of sexually transmitted infections among South African women: Implications of combined impacts of risk factors (2020) (9)
Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article. (2014) (9)
Baseline Predictors of High Adherence to a Coitally Dependent Microbicide Gel Based on an Objective Marker of Use: Findings from the Carraguard Phase 3 Trial (2015) (9)
Sodium dodecyl sulphate polyacrylamide gel electrophoresis of urinary proteins in steroid-responsive and steroid-resistant nephrotic syndrome in children (1994) (8)
Effects of Partnership Change on Microbicide Gel Adherence in a Clinical Trial (HPTN 035) (2014) (8)
Poor Performance of the Chlamydia Rapid Test Device for the Detection of Asymptomatic Infections in South African Men: A Pilot Study (2016) (8)
To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa (2015) (8)
Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women (2004) (8)
Contraception use and impact on pregnancy prevention in women participating in an HIV prevention trial in South Africa (2015) (7)
Participants as community-based peer educators: Impact on a clinical trial site in KwaZulu-Natal (2013) (7)
Antiretroviral-based microbicides and oral pre-exposure prophylaxis for HIV prevention (2011) (7)
Impact of learning HIV status on contraceptive use in the MIRA trial (2011) (7)
Impact of targeted counseling on reported vaginal hygiene practices and bacterial vaginosis: the HIV Prevention Trials Network 035 study (2017) (7)
Impact of Voluntary HIV Counselling and Testing Among Sex Workers (2000) (7)
Virological remission after antiretroviral therapy interruption in female African HIV seroconverters (2019) (7)
Targeted Pregnancy and Human Immunodeficiency Virus Prevention Risk-Reduction Counseling for Young Women: Lessons Learned from Biomedical Prevention Trials (2018) (7)
Characterization of proteinuria in asymptomatic family members and household contacts of children with hepatitis B virus-associated membranous nephropathy. (2001) (7)
Enhanced normalisation of CD 4 / CD 8 ratio with early antiretroviral therapy in primary HIV infection (2015) (6)
Food insecurity, HIV status and prior testing at South African primary healthcare clinics (2018) (6)
Investigating spatial disparities in high-risk women and HIV infections using generalized additive models: Results from a cohort of South African women. (2019) (6)
Willingness of Clinicians to Integrate Microbicides into HIV Prevention Practices in Southern Africa (2011) (6)
Herpes simplex virus type II infection is a risk factor for HIV seroconversion. (2002) (6)
Geographical-level contributions of risk factors for HIV infections using generalized additive models: results from a cohort of South African women (2018) (6)
Randomised controlled trial testing the effect of cotrimoxazole prophylaxis on morbidity and mortality outcomes in breastfed HIV-exposed uninfected infants: study protocol (2016) (6)
National expenditure on health research in South Africa: How has the landscape changed in the past decade? (2020) (5)
Reducing Women's Risk of HIV Infection: South Africa's Contribution to Microbicide Research and Development (2000) (5)
Predictors of perceived male partner concurrency among women at risk for HIV and STI acquisition in Durban, South Africa (2016) (5)
Clinical and Virologic Outcomes Following Initiation of Antiretroviral Therapy Among Seroconverters in the MTN-020/ASPIRE Phase III Trial of the Dapivirine Vaginal Ring. (2018) (5)
Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial (2018) (5)
Targeted combination HIV prevention packages to halt the global HIV epidemic. (2012) (5)
PIMA™ point-of-care testing for CD4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal, Durban, South Africa (2016) (4)
AIDS prevention in South Africa (2006) (4)
Depletion of glomerular anionic sites and proteineuria in nephrotic syndrome of children. (1997) (4)
Correlates of Sexually Transmitted Infections among South African Women Using Individual and Community Level Factors: Results from Generalized Additive Mixed Models (2019) (4)
Acceptability of a Vaginal Microbicide Among Sex Workers in KwaZulu, Natal, South Africa (1998) (4)
HIV disease progression among women following seroconversion during a tenofovir-based HIV prevention trial (2017) (4)
Biomedical HIV Prevention (2011) (4)
Assessment of the Impact of Rapid Point-of-Care CD4 Testing in Primary Healthcare Clinic Settings: A Survey Study of Client and Provider Perspectives (2020) (4)
The Impact of Male Partner Circumcision on Women's Health Outcomes. (2020) (4)
Identifying Factors Associated with Low-Adherence and Subsequent HIV Seroconversions Among South African Women Enrolled in a Biomedical Intervention Trial (2017) (3)
No evidence for naturally occurring mutations resistant to HIV-1 reverse-transcriptase inhibitors among South African HIV-1 subtype C isolates (2000) (3)
Utility of colposcopy in a phase 2 portion of a microbicide clinical trial of BufferGel and 0.5% PRO 2000 Gel (2012) (3)
Total parenteral nutrition with the '3-litre bag': effect of fat emulsion on amino acid kinetics and nitrogen balance in patients with intestinal fistulae. (1984) (3)
Temporal trends in sexual behaviours and their impacts on HIV incidence among South African women: 2002–2016 (2020) (3)
Tenofovir-Based Pre-exposure for HIV Infection among African Women (2014) (3)
Assessment of informed consent in the Microbicide Development Programme feasibility study Durban, South Africa. (2006) (3)
Association of endogenous progesterone levels in young women using hormonal contraception with recent HIV-1 infection (2019) (3)
Prevention, Partners, and Power Imbalances: Women's views on how male partners affected their adherence to vaginal microbicide gels during HIV prevention trials in Africa. (2020) (3)
Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa. (2020) (3)
Evaluation of a health system intervention to improve virological management in an antiretroviral programme at a municipal clinic in central Durban (2019) (3)
Need for a true placebo for vaginal microbicide efficacy trials (2003) (3)
Patterns and predictors of adherence in a phase III trial in Sub-Saharan Africa: a Trajectory Analysis (2009) (2)
Safe Sex Practices Among Sex Workers at Risk of HIV Infection (1998) (2)
Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]. (2016) (2)
Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women (2019) (2)
The role of progestins in HIV acquisition in young women. (2016) (2)
P3.090 Bacterial Vaginosis and the Risk of Trichomonas Vaginalis Acquisition Among HIV-1 Negative Women (2013) (2)
Characteristics Associated with HIV Drug Resistance Among Women Screening for an HIV Prevention Trial in KwaZulu-Natal, South Africa (2015) (2)
Analyzing Continuous Measures in HIV Prevention Research Using Semiparametric Regression and Parametric Regression Models: How to Use Data to Get the (Right) Answer? (2012) (2)
HIV-prevention research in South Africa (2008) (2)
Response to Brown et al., 'Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe'. (2007) (2)
The road ahead: working towards effective clinical translation of biomedical HIV prevention strategies (2015) (2)
Linkage to Care Following an HIV Diagnosis in Three Public Sector Clinics in eThekwini (Durban), South Africa: Findings from a Prospective Cohort Study (2019) (2)
Notes on the Frequency of Routinely Collected and Self-Reported Behavioral Data in HIV Prevention Trials (2011) (2)
Enrichment of the HIV reservoir in CD32+ CD4 T cells occurs early in blood and tissue (2017) (2)
Preventing co-enrolment in multiple clinical trials in Durban, South Africa. (2006) (2)
Quantifying geographical diversity in sexually transmitted infections using population attributable risk: results from HIV prevention trials in South Africa (2021) (2)
Responding to the ECHO trial results: modelling the potential impact of changing contraceptive method mix on HIV and reproductive health in South Africa (2020) (2)
Women design their own vaginal microbicide trial: Suggestions on how to improve adherence from former participants of HIV prevention trials (2021) (2)
Predictors of antiretroviral therapy initiation in eThekwini (Durban), South Africa: Findings from a prospective cohort study (2021) (2)
Altered Erythrocyte Charge in Afri can Women with Early-Onsetpreeclampsia (1994) (2)
OC 8491 PREPVACC: A PHASE III, MAMS ADAPTIVE PROPHYLACTIC HIV VACCINE TRIAL WITH A SECOND RANDOMISATION TO COMPARE F/TAF WITH TDF/FTC PREP (2019) (2)
HSV2 prevalence amongst women participating in HIV prevention studies in rural communities in Durban, South Africa -urgent need for microbicide product to be active against HSV2. (2006) (2)
Prevention in South Africa (2006) (1)
Discrepancies in diagnosis of incident HIV infection between antibody- and DNA-based tests in a phase III prevention trial in southern Africa (2012) (1)
AIDS prevention in South Africa : prevention (2006) (1)
Health Seeking Behaviour With Reference to Sexually Transmitted Infections Among Sex Workers in South Africa (2000) (1)
Evaluating HIV prevention efforts using semiparametric regression models: results from a large cohort of women participating in an HIV prevention trial from KwaZulu-Natal, South Africa (2013) (1)
HLA Associations With HIV-1 Seronegative Sex Workers From KwaZulu-Natal, South Africa (2000) (1)
Ethical considerations in implementing a biometric co-enrolment prevention system in clinical trials in South Africa (2016) (1)
A developing country response to Lavery et al. "In global health research, is it legitimate to stop clinical trials early on account of their opportunity costs?" (2009) (1)
Cohort effects on sexual behavior and risk of acquisition of sexually transmitted infections and HIV in a South African HIV prevention trial (2018) (1)
Prevalence and Incidence of Sexually Transmitted Infection in Injectable Progestin Contraception Users in South Africa (2021) (1)
Unrecognized genital ulcer disease among rural South African women. (1998) (1)
Comparison of noninvasive methods steroid-sensitive nephrotic syndrome glomerulosclerosis for distinguishing from focal (1997) (1)
Shared responsibility for ensuring appropriate management of incidental findings: a case study from South Africa (2014) (1)
HIV/AIDS in South Africa: Female sex workers (2010) (1)
Clinical Significance of Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis of Urinary Proteins in Preeclampsia (1997) (1)
Randomization scheme and study assessments (2011) (0)
Predictors of perceived male partner concurrency among women at risk for HIV and STI acquisition in Durban, South Africa. (2016) (0)
O131 Provider HIV and pregnancy prevention in South Africa: the female condom (2009) (0)
Sharing of Investigational Drug Among Participants in the Voice Trial (2016) (0)
Exploring the immunomodulatory role of depot medroxyprogesterones acetate and endogenous progesterone levels in HIV infected and uninfected women (2019) (0)
4 Post-treatment control or treated controllers? The impact of ART on time to viral rebound in recent seroconverters (2016) (0)
Quantifying Vulnerabilities of Single Women and Sexually Transmitted Infections in South Africa (2002–2016): Is It Getting Better (or Worse)? (2021) (0)
Hum. Reprod.-2014-Crook-humrep-deu113 (2014) (0)
Spatial variations in STIs among women enrolled in HIV prevention clinical trials in Durban, KwaZulu-Natal, South Africa (2023) (0)
Correction: Prevalence of HIV-1 Drug Resistance among Women Screening for HIV Prevention Trials in KwaZulu-Natal, South Africa (MTN-009) (2014) (0)
Contraceptive use and sexual health behaviors among newly-diagnosed HIV-positive South African women and men (2013) (0)
Socio-demographic and behavioural characteristics associated with HSV-2 sero-prevalence in high risk women in KwaZulu-Natal (2015) (0)
Ethical and legal issues in infectious disease research and control. (2001) (0)
Patterns andPredictors of Adherence toDiaphragmUse in a Phase III Trial in Sub-SaharanAfrica: A Trajectory Analysis (2009) (0)
Enhanced Normalization of CD 4 / CD 8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection (0)
Original research article Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article ☆,☆☆,★ (2014) (0)
Response to Treatment for Syphilis Among HIV Positive and Negative Sexworkers in KwaZulu/Natal, South Africa (2000) (0)
ACCEPTABILITY OF A VAGINAL MICROBICIDE AMONG FEMALE (1999) (0)
High risk sexual behaviors are associated with sexual violence among a cohort of women in Durban, South Africa (2013) (0)
International Congress of Drug Therapy in HIV Infection 2‐6 November 2014, Glasgow, UK (2014) (0)
Targeted pregnancy and HIV prevention risk-reduction counselling for young women: lessons learned from biomedical prevention trials Running Title HIV and pregnancy risk-counselling in prevention trials Authors (2019) (0)
Correlates of Sexually Transmitted Infections Among South African Women Using Individual- and Community-Level Factors: Results from Generalized Additive Mixed Models (2019) (0)
Prevalence of Herpes Simplex Virus 2 (HSV-2) infection and associated risk factors in a cohort of HIV negative women in Durban, South Africa (2016) (0)
Impact of hormonal contraceptives on the incidence of HIV infection and pregnancy rates in a cohort of women in Durban , South Africa (2012) (0)
Contraceptives and sexual behaviours in predicting pregnancy rates in HIV prevention trials in South Africa: Past, present and future implications. (2020) (0)
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort (2021) (0)
5: Injectable progestin contraception and vaginal infection among south african women participating in the VOICE trial (2015) (0)
Studies on multiply exposed but persistently HIV-1 seronegative sex workers from KwaZulu/Natal, South Africa (2000) (0)
Microbicides for HIV prevention: theory and future prospects (2013) (0)
Pilot study to predict estimated screening sample size for Phase III Microbicide Trial. (2006) (0)
NONOXYNOL‐9 DOES NOT PREVENT SEXUALLY TRANSMITTED INFECTIONS (2003) (0)
Issues surrounding the implementation of multiple product development partnership clinical trials in developing countries. (2008) (0)
HERPES S SIMPLEX V VIRUS T TYPE III IINFECTION IIS A A RISK F FACTOR F FOR H HIV S SEROCONVERSION (2002) (0)
PREECLAMPSIA AFRICAN WOMEN WITH EARLY-ONSET (1994) (0)
African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the MIRA trial (2010) (0)
The challenge of collecting, collating and reporting adverse event data in microbicide trials. (2006) (0)
Erratum to: Sharing of Investigational Drug Among Participants in the Voice Trial (2016) (0)
Undiagnosed genital infections among women participating in an MDP Pilot study as a result of lack of acknowledgement of abnormal symptoms. (2006) (0)
Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome for countries in transition: PART 3: Surveillance for human immunodeficiency virus/acquired immunodeficiency syndrome in South Africa (2013) (0)
Discrepancies in diagnosis of incident HIV infection between antibody-based and DNA-based tests in a Southern African phase III prevention trial (2012) (0)
Principal Investigator (PI) on the Notice of Grant (2010) (0)
community-based HIV prevention trials among women in KwaZulu-Natal, South Africa (2010) (0)
If women use the microbicide nonoxynol-9 during vaginalsex with men, does it protect them from HIV? Evidence Update, HIV/AIDS Series, October 2004 (2004) (0)
The acceptability of a placebo gel in preparation for the Microbicides Development Programme Phase III Trial in Durban, South Africa. (2006) (0)
HIV prevention research unit: Who we are and what we do. (1969) (0)
PIMATM point-of-care testing for CD 4 counts in predicting antiretroviral initiation in HIV-infected individuals in KwaZulu-Natal , Durban , South Africa (2016) (0)
Prevalence of anaemia in women at screening and follow-up in a microbicide phase III trial. (2007) (0)
Clinical Study Sexually Transmitted Infections in Women Participating in a Biomedical Intervention Trial in Durban : Prevalence , Coinfections , and Risk Factors (2015) (0)
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence (2021) (0)
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection SPARTAC cohort. (2021) (0)
Contraceptive use and uptake. (2007) (0)
Evaluation of the OneStep Gonorrhea RapiCard InstaTest for Detection of Neisseria gonorrhoeae in Symptomatic Patients from KwaZulu-Natal , South Africa (2015) (0)
Microbicides 2006 Conference : Conference Report (2006) (0)
Intravaginal Substance Use and Douching Practices Among Sex Workers in South Africa: Implications for Microbicide Use (1998) (0)
Using next generation sequencing to unravel the molecular epidemiology of the drug-resistant TB epidemic in the Eastern Cape (2014) (0)
HSV 2 Prevalence Amongst Women Participating in HIV Prevention Studies in rural communities in Durban , South Africa-Urgent need for Microbicide Product to be Active Against HSV 2 (2008) (0)
Letters to the Editor (1998) (0)
Quantifying Vulnerabilities of Single Women and Sexually Transmitted Infections in South Africa (2002–2016): Is It Getting Better (or Worse)? (2021) (0)

This paper list is powered by the following services:

Other Resources About Gita Ramjee

en.wikipedia.org

What Schools Are Affiliated With Gita Ramjee?

Gita Ramjee is affiliated with the following schools: